Unlock Premium Data: Up to 50% Off InvestingProCLAIM SALE


OTC Markets
Currency in USD

GLAXF Price Commentary

Will it exceed 1800 and stay their is the question
more enough 5 year high. now will it smash through that high is the question.....
Nov 1 call coming correct
did anyone act on my call.
triple buy. tgt 1900
All export earners today are going south
Lovely little boost from the Zantec case today. Let's hope the shares kick onwards from here
ITH stock
Bought back all the gsk that I sold back in May. It's a no brainer at this price
You are right. Also the price has been range bound for a decade and we are now near to the lower bound. I've heard similar comments to you nearly ever year when it's price is underperforming
I wish the institutional shareholders would wake up and do something about the management team. Surely with such an abysmal performance over so long GSK must be a takeover target?
I'm only interested in swing trading this counter. If the price doesn't move I'll just collect dividends while waiting for it to bounce. The spinoff of Haleon is a good move as in this day and age companies need to be pure play to get ahead of competition. Consumer healthcare business was a distraction to their management.
new management required
Bloodbath coming
Hi John, it will be worsth ?
When will this carnage start, exacty (02/11/22)
Should have taken the Unilever offer...
It was madness not to.
Demerger yet another damp squib in a long line of failures by Walmsley. She is unprecedented in her ability to talk the talk but to not walk the walk!
This may go up further but I've started to take some profit as precaution. I suspect ulvr may not revise their offer after its sp tanking showing clear sentiments from shareholding to reject this move
Moving closer to my 1800 tgt (posted on March 30). This stock pays very generous dividend I have to say
ex-div in 13 days time. why risk selling now when you might not get back on the boat? pretty sure the company split will reach equivalent of 2000+ for the two new companies.
1587.80 looking at my previous comment "what do i know" near yearly HIGHS
Breakout. Strong buy
1399.60p described as a good Divi stock but where's the potential capital growth... will wait for sub 1200.00p
The current CEO seems to have lost confidence, time for a change to inject new life into the company
the news from today remarked that investors present applauded during the event.
the question is what percentage of GSK shareholders attended, most big investors gont go to such events
while true, until we know who attended it's hard to gauge lost confidence. at the start of the day pre share holder day, the share price was 20p down, that swung to 40p up at one point, hardly signals negativity
Seems to me that a stake is being built, especially from the area of £13.25 upwards. We already have the "activist" investment fund but another buyer is around. Seems similar to whats been happening in BT shares over the last few weeks. Stay long and collect dividends on the way. Hopefully
what will happen when the split happens in 2022?!
There is absolutely value at its 12m lows 1190.00 so I'm waiting for any bad news and will buy in the dips.... Are THEY PAYING A Dividend???
Yes, 23p per share last time round in April
I believe the next dividend, may 20th, is 19p.
thanks Paul , Simon.
Broken above descending channel. Very likely to be start of a bull run.
One of the most undervalued stock in ftse100
The market hates that the dividend is being reduced next year to 50p
Huge debt
Manageable debt like Abbvie
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.